Anixa Biosciences Inc. (ANIX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Anixa Biosciences Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$3.37
+2.74% today
Market cap
$114M
Overall quality
57/100
Kronos AI 30-day
−1.7%
4 of 8 simulated paths end higher
Anixa Biosciences Inc. (ANIX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $114M. It trades at $3.37, up 2.74% today. Its overall quality score is 57 out of 100, ranked against the whole US market. 2 analysts' average target of $10.00 implies +196.7% from today's price. Kronos AI's 30-day forecast is −1.7% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.00 |
| Low – high | $6.00 – $14.00 |
| Analysts | 2 |
| Upside to average | +196.7% |
Kronos AI 30-day forecast
| Expected close | $3.22 (−1.7%) |
| Likely range | −11.1% … +6.5% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 39 |
| Solvency | 86 |
| Growth | 46 |
| Overall | 57 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.